Search

everythinglearnresearchcommunity

for

Search:↓

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

PCOS increases the risk of heart disease and type 2 diabetes in women.

There's no significant link between blood fat levels and male pattern baldness.

There is no significant link between male pattern baldness and insulin resistance.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Many men with androgenic alopecia also have dyslipidemia.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

The hCG diet and testosterone therapy can cause hair loss in some people.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Hair loss in Chinese college students leads to various psychological issues, so treatment should address both hair loss and mental health.

Early-onset AGA shows different hair and metabolic characteristics compared to normal-onset AGA.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Androgenetic alopecia may be linked to metabolic syndrome.

Muscles can make their own androgens, which may help muscle growth.

Androgens play a key role in causing PCOS (Polycystic Ovary Syndrome).

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Hair transplantation is a viable treatment for some types of female hair loss, with careful donor assessment and attention to psychological factors.